- ICH GCP
- EU臨床試験登録
最新の試験
EudraCT Number: 2004-001904-10 | Sponsor Protocol Number: PM0259CA301J1 | Start Date: 2004-09-15 | ||||||
Sponsor Name: Pierre Fabre Médicament represented by IRPF | ||||||||
Full Title: Prospective randomised clinical phase III trial of (alternating IV and oral) vinorelbine plus cisplatin versus docetaxel plus cisplatin in first line chemotherapy of locally advanced or metastatic ... | ||||||||
Medical condition: Treatment in locally advanced or metastatic non-small-lung cancer. | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: AT (Completed) EE (Prematurely Ended) | ||||||||
Trial results: View results |
EudraCT Number: 2004-000329-31 | Sponsor Protocol Number: EORTC 22011- 40014 | Start Date: 2004-09-15 | |||||||||||
Sponsor Name: E.O.R.T.C. - EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER | |||||||||||||
Full Title: Continuous fluorouracil plus mitomycin C versus mitomycin C plus Cisplatin as chemotherapy combination in combined radiochemotherapy for locally advanced anal cancer. A phase II-III study | |||||||||||||
Medical condition: Locally Advanced Anal Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001490-26 | Sponsor Protocol Number: CRx-150-002-00 | Start Date: 2004-09-15 | ||||||
Sponsor Name: CombinatoRx, Inc | ||||||||
Full Title: A SINGLE-CENTER, RANDOMIZED, SINGLE-BLIND STUDY COMPARING THE EFFECT OF CRx-150 PLUS DMARD THERAPY TO THAT OF PLACEBO PLUS DMARD THERAPY ON SERUM C-REACTIVE PROTEIN (CRP) AND CYTOKINES IN SUBJECTS ... | ||||||||
Medical condition: RHEUMATOID ARTHRITIS | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) EE (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000139-27 | Sponsor Protocol Number: A509 1018 | Start Date: 2004-09-14 | |||||||||||
Sponsor Name: Pfizer AB | |||||||||||||
Full Title: A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Parallel Group, Multicenter Study of the Efficacy, Safety, and Tolerability of Fixed Combination Torcetrapib/Atorvastatin Administered Orall... | |||||||||||||
Medical condition: Mixed dyslipidemia (Frederickson Types IIa and IIb) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004675-11 | Sponsor Protocol Number: 133/2004/U | Start Date: 2004-09-14 | |||||||||||
Sponsor Name: AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: Clinical trial of phase II for the a front line treatment of the non-Hodgkin lymphomas of derivation lymphocyte T Gemcitabine and Oxaliplatin GEMOX | |||||||||||||
Medical condition: Non Hodgkin s disease of lymphocyte T derivation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001549-13 | Sponsor Protocol Number: VAR102372 | Start Date: 2004-09-14 | |||||||||||
Sponsor Name: GLAXO SMITHKLINE | |||||||||||||
Full Title: A pilot, randomized, double-blind, placebo-controlled, crossover study evaluating the efficacy and safety of Vardenafil versus placebo administered 12, 18 and 24 hours prior to initiation of sexual... | |||||||||||||
Medical condition: ERECTILE DISFUNCTION | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-003355-39 | Sponsor Protocol Number: E2020-E044-318 | Start Date: 2004-09-14 | ||||||
Sponsor Name: Eisai Limited | ||||||||
Full Title: A 52-week, multicentre, open label extension study of the safety, tolerability and efficacy of donepezil (Aricept) in Parkinson's disease patients with dementia. | ||||||||
Medical condition: Dementia associated with Parkinson's disease | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: AT (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-000156-16 | Sponsor Protocol Number: A509 1043 | Start Date: 2004-09-14 | |||||||||||
Sponsor Name: Pfizer AB | |||||||||||||
Full Title: Phase 3 multi center, double blind, randomized, parallel group evaluation of the fixed combination torcetrapib/atorvastatin, administered orally, once daily (QD), compared with atorvastatin alone, ... | |||||||||||||
Medical condition: Coronary Heart Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) ES (Completed) GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000134-37 | Sponsor Protocol Number: 20010184 | Start Date: 2004-09-14 | |||||||||||
Sponsor Name: Amgen Inc. | |||||||||||||
Full Title: Trial to Reduce Cardiovascular Events with Aranesp Therapy | |||||||||||||
Medical condition: Treatment of anaemia in subjects with chronic kidney disease (CKD) amd Type 2 diabetes mellitus (DM) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) SK (Completed) CZ (Completed) LV (Completed) SE (Completed) IT (Completed) DK (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001450-84 | Sponsor Protocol Number: XM02-03-INT | Start Date: 2004-09-14 | ||||||
Sponsor Name: BioGeneriX | ||||||||
Full Title: Safety and Efficacy of XM 02 in patients with small cell or non small cell lung cancer receiving platinum-based chemotherapy. Multinational, multicentre, randomised, controlled study | ||||||||
Medical condition: Patients with small cell or non small cell lung cancer receiving platinum-based chemotherapy and developing Neutropenia due to chemotherapy. | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: HU (Completed) LT (Completed) | ||||||||
Trial results: (No results available) |